← Leaderboards
Hilary A. Robbins
Johns Hopkins University
$2,189,062
Attributed
$2,189,062
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $660.2K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,189,062 · 3
By mechanism
R01$1,995,233 · 1
R03$112,170 · 1
F31$81,659 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Joseph B. Margolick$86,818,342
- Todd T Brown$33,742,320
- Lisa P Jacobson$80,226,469
- Gypsyamber D'souza$25,879,984
- Chloe L Thio$13,807,555
Others in their field
Top investigators on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- David Heimbrook · Leidos Biomedical Research, Inc.$277,323,479
- Richard A Gibbs · Baylor College Of Medicine$249,395,936
- David R. Weir · University Of Michigan At Ann Arbor$236,797,614
- Peter B. Gilbert · Fred Hutchinson Cancer Center$153,633,436
- Ralph Parchment · Leidos Biomedical Research, Inc.$135,017,102
Research focus
ScreeningCancer EtiologyCancer RiskDetectionBiopsyHigh RiskMalignant NeoplasmsModel DevelopmentScreening ProgramTranslatingMortalitySmokingEquilibriumPredictive ModelingCessation Of LifeLung Cancer ScreeningFollow-UpLungLow Dose Computed TomographyMalignant Neoplasm Of LungDiagnostic ProcedureEnsureBiological MarkersBenign
Grant awards (7)
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening$660,204
R01 · FY2025 · CA · contact PI
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening$452,301
R01 · FY2024 · CA · contact PI
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening$451,746
R01 · FY2023 · CA · contact PI
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening$430,982
R01 · FY2022 · CA · contact PI
Evaluating risk prediction models for use in lung cancer screening in diverse populations around the world$112,170
R03 · FY2020 · CA · contact PI
Optimizing Screening for HPV-related Cancers among People Living with HIV$38,083
F31 · FY2017 · CA · contact PI
Optimizing Screening for HPV-related Cancers among People Living with HIV$43,576
F31 · FY2016 · CA · contact PI